|
| EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- Basic information |
Product Name: | EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- | Synonyms: | EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-;Edoxaban iMpurity G;N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4R)-4-(diMethylcarbaMoyl)-2-(5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxaMido)cyclohexyl)oxalaMide;Edoxaban Isomer (SRR);4-epi-Edoxaban;Edoxaban Impurity S;N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4R)-4-[(dimethylamino)carbonyl]-2-{[5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide;Edoxaban EP Impurity G | CAS: | 1255529-26-0 | MF: | C24H30ClN7O4S | MW: | 548.06 | EINECS: | | Product Categories: | | Mol File: | 1255529-26-0.mol | |
| EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- Chemical Properties |
density | 1.43±0.1 g/cm3(Predicted) | pka | 9.46±0.70(Predicted) |
| EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- Usage And Synthesis |
Uses | 4-epi-Edoxaban is a derivative of Edoxaban (E555520) an anticoagulant drug which acts as a direct factor Xa inhibitor. |
| EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- Preparation Products And Raw materials |
|